COVID-19 and the Developement of Phobic Fears of Disease
NCT04359121 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2023-01-11
Summary
A lot of people suffer from phobias. Phobias concerning certain diseases are not rare. This study will examine whether the COVID-19 (Coronavirus Disease) crisis was able to rise phobias in people and if those with preexisting phobias or fears were more likely to develop a phobia concerning COVID. It will look at different subtypes - physicians, medical staff, general public (not medically affiliated) and patients with psychiatric disorders.
Conditions
- COVID19
Interventions
- OTHER
-
Questionnaires for specific phobia
Questionnaires will be used.
Sponsors & Collaborators
-
Medical University of Graz
lead OTHER
Principal Investigators
-
Andreas Baranyi, Prof. · Medical University of Graz
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-12-15
- Primary Completion
- 2023-11-15
- Completion
- 2023-11-15
Countries
- Austria
Study Locations
More Related Trials
-
Impact of Premedication on Anxiety
NCT04103723 ·Status: UNKNOWN
-
Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety
NCT06564402 ·Status: RECRUITING ·Phase: NA
-
Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders
NCT03033056 ·Status: COMPLETED
-
Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety
NCT00842946 ·Status: COMPLETED ·Phase: NA
-
Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans
NCT05120635 ·Status: RECRUITING ·Phase: NA
-
D-cycloserine Augmented CBT for Panic Disorder
NCT01680107 ·Status: TERMINATED ·Phase: PHASE3
-
Quetiapine in Specific Phobia
NCT00872716 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment for Specific Phobias in Children
NCT00051220 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia
NCT00515879 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia
NCT00380731 ·Status: COMPLETED ·Phase: NA
-
Impact of COVID-19 on Mental Health of OCD Patients and live-in Family Members
NCT05656456 ·Status: COMPLETED
-
D-Cycloserine Enhancement of Exposure in Social Phobia
NCT00633984 ·Status: COMPLETED ·Phase: PHASE4
-
Generalized Fear Extinction to Untreated Fear Stimuli in Specific Phobias After Exposure
NCT03907345 ·Status: COMPLETED ·Phase: NA
-
Brief Intervention to Reduce Fear of Public Speaking
NCT02790736 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Stress on Exposure Therapy
NCT03505437 ·Status: COMPLETED ·Phase: NA
-
A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic
NCT04341922 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Treatment for Panic Disorder
NCT00456768 ·Status: COMPLETED
-
Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic
NCT04365972 ·Status: COMPLETED ·Phase: NA
-
Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis
NCT01119469 ·Status: COMPLETED ·Phase: PHASE3
-
Optimizing Exposure Therapy Via Reward-focused Interventions in Individuals With Public Speaking Anxiety
NCT06258889 ·Status: COMPLETED ·Phase: NA
-
Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure
NCT00245609 ·Status: COMPLETED ·Phase: PHASE2
-
Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice
NCT01388231 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
An Online Large-group One-session Treatment for Public Speaking Anxiety
NCT04790864 ·Status: COMPLETED ·Phase: NA
-
St. John's Wort Versus Placebo in Social Phobia
NCT00035412 ·Status: COMPLETED ·Phase: PHASE2
-
Neurophysiological Correlates of Exposition Therapy in Spider Phobia
NCT03653923 ·Status: UNKNOWN ·Phase: NA